Astellas Pharma Stock Price (OTCMKTS:ALPMY)

Add to My Stocks
$17.95 $0.14 (0.79%) ALPMY stock closing price Sep 20, 2018 (Closing)
Prev Close* : $17.81
Market Cap:
$35.25B
Day Low: $17.9
52 Week Low: $12.34
Open: $17.9
Volume: -
Day High: $17.99
52 Week High: $17.99
Dividend:
0.23

Latest Stock Market News

Latest Articles

Astellas Pharma News - From Partners

ALPMY Stockcharts

View ALPMY PE ratio, PS ratio stocks charts and compare with peers.
ALPMY Chart
Note: Compare Astellas Pharma stock price history with the index and industry peers.

Astellas Pharma Valuation

PE ratio
(price earnings ratio)
22.72
PS ratio (
price to sales ratio
)
2.99
PB ratio (
price to book ratio
)
2.98

Astellas Pharma Returns

ROE
(return on equity)
14%

Astellas Pharma Financial Ratios

Asset Turnover
0.72
Receivables Turnover
3.86
Debt to Equity
0.05
Dividend Yield
1.34%

ALPMY Industry Peers

Company Price Change (%)
Shire (SHPG)179.981.4 (0.78%)
Zoetis (ZTS)90.060.98 (1.1%)
Pfizer (PFE)43.750.49 (1.13%)
Eisai (ESALY)94.980.76 (0.81%)
Astrazeneca (AZN)37.720.42 (1.13%)
Merck (MRK)70.780.8 (1.14%)
Gilead Sciences (GILD)74.830.95 (1.29%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Galectin Therapeutics (GALT)6.930.88 (14.55%)
Lannett Co (LCI)5.50.65 (13.4%)
TherapeuticsMD (TXMD)6.750.53 (8.52%)
Akebia Therapeutics (AKBA)8.330.59 (7.62%)
ArQule (ARQL)5.150.3 (6.19%)
Enanta Pharma (ENTA)97.685.59 (6.07%)
CTI BioPharma (CTIC)2.010.1 (5.24%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Rigel Pharma (RIGL)3.320.27 (7.52%)
MOLECULAR TEMPL (MTEM)5.790.46 (7.36%)
Achaogen (AKAO)4.310.25 (5.48%)
Flexion Therapeutics (FLXN)18.870.75 (3.82%)
CORREVIO PHARMA (CORV)4.290.1 (2.28%)
Heron Therapeutics (HRTX)33.10.6 (1.78%)
Portola Pharma (PTLA)28.170.46 (1.61%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

ASTELLAS PHARMA UNSP ADR EACH REPR 0.25 ORD Stock News - Partner Headlines

Astellas Pharma Financial Statements

income statement20182017201620152014
Net Sales or Revenues12B11.71B11.39B11.35B11.07B
Net Income1.52B1.95B1.61B1.24B882M
Total Operating Expense06.52B6.54B6.63B6.73B
View Astellas Pharma income statement
balance sheet20172016201520142013
Total Assets16.26B14.93B16.32B16.05B15.38B
Total Liabilities4.9B4.48B4.33B3.73B4.08B
Shareholders Equity11.36B10.45B11.99B12.32B11.3B
View Astellas Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-53M-1.25B-461.67M-578M-708M
Net Cash from (used by) Operating Activities2.1B2.6B1.71B2.08B1.53B
Increase (Decrease) in Prop Plant And Equipment-248M-263.59M-170.25M-200M-325M
View Astellas Pharma cash flow statement

Astellas Pharma Stock Message Board

An investor needs to spend $17.95 to buy ALPMY stock, as the closing Astellas Pharma stock price is $17.95. The total market value as denoted by $35.25B for Astellas Pharma, is the market value of the company's outstanding shares. Astellas Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Astellas Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 152,292 shares were traded with a closing stock price of $17.95 as of Sep 20, 2018, as can be seen from Astellas Pharma stock quote. One can view Astellas Pharma stock chart to follow the stock price trend. Astellas Pharma paid 0.23 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of ALPMY, view Astellas Pharma stock price history.